Michael J. Messino

1.7k total citations
33 papers, 950 citations indexed

About

Michael J. Messino is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Michael J. Messino has authored 33 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Physiology. Recurrent topics in Michael J. Messino's work include Cancer survivorship and care (9 papers), Cancer-related cognitive impairment studies (6 papers) and Nutrition and Health in Aging (6 papers). Michael J. Messino is often cited by papers focused on Cancer survivorship and care (9 papers), Cancer-related cognitive impairment studies (6 papers) and Nutrition and Health in Aging (6 papers). Michael J. Messino collaborates with scholars based in United States, Canada and France. Michael J. Messino's co-authors include Hyman B. Muss, Trevor A. Jolly, Samara Ann Dixon, Shani Alston, Grant R. Williams, Allison M. Deal, W. Chris Taylor, Al B. Benson, Robert J. Mayer and Hedy L. Kindler and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Michael J. Messino

31 papers receiving 926 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael J. Messino United States	14	475	309	215	205	147	33	950
C. Blanc-Bisson France	11	289 0.6×	510 1.7×	199 0.9×	472 2.3×	130 0.9×	23	1.0k
G. J. van Londen United States	18	449 0.9×	126 0.4×	190 0.9×	62 0.3×	132 0.9×	44	845
Giorgio Astara Italy	17	335 0.7×	449 1.5×	173 0.8×	90 0.4×	58 0.4×	49	1.2k
Carmela Pepe Canada	13	418 0.9×	489 1.6×	697 3.2×	112 0.5×	40 0.3×	37	1.2k
Fränzel J.B. van Duijnhoven Netherlands	20	693 1.5×	323 1.0×	186 0.9×	44 0.2×	200 1.4×	67	1.2k
Kathy Pan United States	16	604 1.3×	253 0.8×	133 0.6×	56 0.3×	238 1.6×	76	1.4k
Zhezhou Huang China	14	194 0.4×	123 0.4×	63 0.3×	93 0.5×	87 0.6×	35	748
Satoru Iwase Japan	14	330 0.7×	92 0.3×	151 0.7×	32 0.2×	112 0.8×	44	693
Matthew Barber United Kingdom	15	290 0.6×	457 1.5×	61 0.3×	53 0.3×	119 0.8×	33	1.4k
Iliana C. Lega Canada	17	328 0.7×	105 0.3×	100 0.5×	44 0.2×	101 0.7×	49	1.1k

Countries citing papers authored by Michael J. Messino

Since Specialization

Citations

This map shows the geographic impact of Michael J. Messino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Messino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Messino more than expected).

Fields of papers citing papers by Michael J. Messino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Messino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Messino. The network helps show where Michael J. Messino may publish in the future.

Co-authorship network of co-authors of Michael J. Messino

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Messino. A scholar is included among the top collaborators of Michael J. Messino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Messino. Michael J. Messino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Po‐Ju, Brian J. Altman, Nikesha Gilmore, et al.. (2023). Effect of Yoga and Mediational Influence of Fatigue on Walking, Physical Activity, and Quality of Life Among Cancer Survivors. Journal of the National Comprehensive Cancer Network. 21(2). 153–162.e2. 10 indexed citations

Algazi, Alain P., Megan Othus, Adil Daud, et al.. (2020). Abstract CT013: SWOG S1320: Improved progression-free survival with continuous compared to intermittent dosing with dabrafenib and trametinib in patients with BRAF mutated melanoma. Cancer Research. 80(16_Supplement). CT013–CT013. 4 indexed citations

Algazi, Alain P., Megan Othus, Adil Daud, et al.. (2020). Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial. Nature Medicine. 26(10). 1564–1568. 67 indexed citations

Algazi, Alain P., Megan Othus, Adil Daud, et al.. (2020). Association of prior immune checkpoint blockade (ICB) with longer progression-free survival (PFS) in patients treated with intermittent versus continuous dabrafenib and trametinib: A post-hoc analysis of S1320.. Journal of Clinical Oncology. 38(15_suppl). 10039–10039.

Dressler, Lynn G., Gillian C. Bell, Mark Steciuk, et al.. (2019). Implementing a Personalized Medicine Cancer Program in a Community Cancer System. Personalized Medicine. 16(3). 221–232. 6 indexed citations

Blarigan, Erin L. Van, Charles S. Fuchs, Donna Niedzwiecki, et al.. (2018). Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance). Cancer Epidemiology Biomarkers & Prevention. 27(4). 438–445. 50 indexed citations

Lawrence, Julia, Laura D. Baker, Ernie Balcueva, et al.. (2017). National Institute on Aging /Alzheimer’s Association criteria for Mild Cognitive Impairment applied to chemotherapy treated breast cancer survivors. PubMed. 1(1). 1–19. 7 indexed citations

Fuchs, Charles S., Donna Niedzwiecki, Xing Ye, et al.. (2017). Long-chain omega-3 fatty acid and fish intake after colon cancer diagnosis and disease-free, recurrence-free, and overall survival in CALGB 89803 (Alliance).. Journal of Clinical Oncology. 35(4_suppl). 585–585. 4 indexed citations

Fuchs, Charles S., Donna Niedzwiecki, Xing Ye, et al.. (2017). American Cancer Society (ACS) Nutrition and Physical Activity Guidelines after colon cancer diagnosis and disease-free (DFS), recurrence-free (RFS), and overall survival (OS) in CALGB 89803 (Alliance).. Journal of Clinical Oncology. 35(15_suppl). 10006–10006. 2 indexed citations

10.

Janelsins, Michelle C., Luke J. Peppone, Charles E. Heckler, et al.. (2015). YOCAS©® Yoga Reduces Self-reported Memory Difficulty in Cancer Survivors in a Nationwide Randomized Clinical Trial. Integrative Cancer Therapies. 15(3). 263–271. 59 indexed citations

11.

Danhauer, Suzanne C., Leah Griffin, Nancy E. Avis, et al.. (2015). Feasibility of implementing a community-based randomized trial of yoga for women undergoing chemotherapy for breast cancer. The Journal of Community and Supportive Oncology. 13(4). 139–147. 16 indexed citations

12.

Gralow, Julie R., William E. Barlow, Alexander Paterson, et al.. (2014). SWOG S0307 phase III trial of bisphosphonates as adjuvant therapy in primary breast cancer: Comparison of toxicities and patient-stated preference for oral versus intravenous delivery.. Journal of Clinical Oncology. 32(15_suppl). 558–558. 9 indexed citations

13.

Williams, Grant R., Allison M. Deal, Trevor A. Jolly, et al.. (2014). Feasibility of geriatric assessment in community oncology clinics. Journal of Geriatric Oncology. 5(3). 245–251. 87 indexed citations

14.

Fuchs, Michael, Kaori Sato, Donna Niedzwiecki, et al.. (2014). Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance). PLoS ONE. 9(6). e99816–e99816. 57 indexed citations

15.

Jeon, Justin Y., Kaori Sato, Donna Niedzwiecki, et al.. (2013). Impact of Physical Activity After Cancer Diagnosis on Survival in Patients With Recurrent Colon Cancer: Findings From CALGB 89803/Alliance. Clinical Colorectal Cancer. 12(4). 233–238. 30 indexed citations

16.

Iqbal, Syma, Cathryn Rankin, Heinz‐Josef Lenz, et al.. (2011). A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202. Cancer Chemotherapy and Pharmacology. 68(6). 1595–1602. 25 indexed citations

17.

Weaver, CH, TJ Moss, B Zhen, et al.. (1998). High-dose chemotherapy in patients with breast cancer: evaluation of infusing peripheral blood stem cells containing occult tumor cells. Bone Marrow Transplantation. 21(11). 1117–1124. 27 indexed citations

18.

Lang, Eric, et al.. (1992). Proliferation of abnormal bone marrow histiocytes, an undesired effect of granulocyte macrophage‐colony‐stimulating factor therapy in a patient with hurler's syndrome undergoing bone marrow transplantation. American Journal of Hematology. 41(4). 280–284. 2 indexed citations

19.

Stein, Robert A., Michael J. Messino, & Eugene A. Hessel. (1990). Anaesthetic implications for bone marrow transplant recipients. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 37(5). 571–578. 7 indexed citations

20.

Gallicchio, Vincent S., et al.. (1989). Effect of various interleukins (IL-1, IL-2, and IL-3) on the in vitro radioprotection of bone marrow progenitors (CFU-GM and CFU-MEG).. PubMed. 8(5). 479–87. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact